Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acotiamide
2. N-(2-(diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-1,3-thiazole-4-carboxamide
3. N-(n',n'-diisopropylaminoethyl)-(2-(2-hydroxy-4,5-dimethoxybenzoylamino)-1,3-thiazole-4-yl)carboxyamide
4. Ym 443
5. Ym-443
6. Ym443 Cpd
7. Z 338
8. Z-338
1. 185104-11-4
2. Acotiamide Hcl
3. Acotiamide (hydrochloride)
4. Z338
5. N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide;hydrochloride
6. Mfcd23103502
7. 510791nn30
8. Ym 443
9. 4-thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-, Monohydrochloride
10. N-[2-(diisopropylamino)ethyl]-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide Hydrochloride
11. Unii-510791nn30
12. N-(2-(diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide Hydrochloride
13. Acotiamidehydrochloride
14. Z-338 Dihydrochloride
15. Acotiamide Dihydrochloride
16. Z 338
17. Schembl6968566
18. Dtxsid30171717
19. Acotiamide Hydrochloride [mi]
20. Akos030529148
21. Hy-121467a
22. Sb19647
23. Acotiamide Hydrochloride [who-dd]
24. Acotiamide Hydrochloride Anhydrous
25. Ds-19577
26. N-(n',n'-diisopropylaminoethyl)-(2-(2-hydroxy-4,5-dimethoxybenzoylamino)-1,3-thiazole-4-yl)carboxyamide
27. N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide Hydrochloride
28. Sy226332
29. Acotiamide Dihydrochloride, >=98% (hplc)
30. Cs-0103547
31. F14757
32. J-011862
33. Q27260838
34. 4-thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-, Hydrochloride (1:1)
35. N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide
1. Acofide
2. Acotiamide Hydrochloride Hydrate
Molecular Weight | 487.0 g/mol |
---|---|
Molecular Formula | C21H31ClN4O5S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 486.1703690 g/mol |
Monoisotopic Mass | 486.1703690 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 586 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20144
Submission : 2007-01-12
Status : Inactive
Type : II
Date of Issue : 2022-06-07
Valid Till : 2025-06-16
Written Confirmation Number : WC-0049
Address of the Firm :
Date of Issue : 2021-01-08
Valid Till : 2023-06-17
Written Confirmation Number : WC-0474A2
Address of the Firm :
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...
About the Company : Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren no...
About the Company : Emnar Pharma was established in 2005, with a drive to become the premier integrated pharmaceuticals company in India. Its business focuses on Contract Manufacturing, Custom Synthes...
About the Company : Hermes Chemical Company Pvt Ltd is a chemicals company established in 2001 and headquartered in Hyderabad. It is specialized in developing, manufacturing, and selling complex molec...
About the Company : Indian Drugs & Chemicals has a wealth of knowledge & expertise that’s incomparable. We utilize this experience to provide both companies & individuals with immersible quality pro...
About the Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kim...
About the Company : Lewens Labs finds its roots in 4 years of engineering during which we saw a dream to carve out a niche for ourselves in Pharmaceutical Industry. As a part of the final year project...
About the Company : Medilux Laboratories has been providing quality back-end support to the pharmaceutical industry since our inception in 1988. Our resources are dedicated to promoting better health ...
About the Company : Virchow Group comprises of six active pharmaceutical ingredient (API) and drug intermediate manufacturing units and two biotech units. Incorporated in 1981, the flagship company of...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Market Place
Reply
19 Jul 2022
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of Acotiamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acotiamide manufacturer or Acotiamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acotiamide manufacturer or Acotiamide supplier.
PharmaCompass also assists you with knowing the Acotiamide API Price utilized in the formulation of products. Acotiamide API Price is not always fixed or binding as the Acotiamide Price is obtained through a variety of data sources. The Acotiamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Acotiamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acotiamide, including repackagers and relabelers. The FDA regulates Acotiamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acotiamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acotiamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acotiamide supplier is an individual or a company that provides Acotiamide active pharmaceutical ingredient (API) or Acotiamide finished formulations upon request. The Acotiamide suppliers may include Acotiamide API manufacturers, exporters, distributors and traders.
click here to find a list of Acotiamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acotiamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Acotiamide active pharmaceutical ingredient (API) in detail. Different forms of Acotiamide DMFs exist exist since differing nations have different regulations, such as Acotiamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acotiamide DMF submitted to regulatory agencies in the US is known as a USDMF. Acotiamide USDMF includes data on Acotiamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acotiamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acotiamide suppliers with USDMF on PharmaCompass.
A Acotiamide written confirmation (Acotiamide WC) is an official document issued by a regulatory agency to a Acotiamide manufacturer, verifying that the manufacturing facility of a Acotiamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acotiamide APIs or Acotiamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Acotiamide WC (written confirmation) as part of the regulatory process.
click here to find a list of Acotiamide suppliers with Written Confirmation (WC) on PharmaCompass.
Acotiamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acotiamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acotiamide GMP manufacturer or Acotiamide GMP API supplier for your needs.
A Acotiamide CoA (Certificate of Analysis) is a formal document that attests to Acotiamide's compliance with Acotiamide specifications and serves as a tool for batch-level quality control.
Acotiamide CoA mostly includes findings from lab analyses of a specific batch. For each Acotiamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acotiamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Acotiamide EP), Acotiamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acotiamide USP).